AI-generated summary
This study protocol describes a planned trial in patients with bipolar disorder and a non-seasonal depressive episode. After one week of placebo, patients are randomized to morning or mid-day bright light therapy with glasses, with exposure escalated in steps up to 45 minutes per day. The authors aim to define a tolerated dose, based on hypomanic symptoms, but report no results.
- Who or what was studied
- Patients with bipolar disorder type I or II and a non-seasonal major depressive episode, treated with a mood stabilizer
- Limits stated in the abstract
- The abstract describes a study protocol only, so no outcomes or efficacy findings are reported, and the number of enrolled participants is not stated.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on psychiatryinvestigation.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Dose, Bright light therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.